BSX Financial Facts
Gross profit: 1.51BOther, net: -33M
See Full Income Statement
See Full Balance Sheet
Boston Scientific (BSX) Earnings
|
Expand Research on BSX
| Next EPS Date | 7/25/24 *Est. | EPS Growth Rate | +19.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +7.5% | Revenue Growth Rate | +13.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/24/24 | Q124 | $0.56 | $0.51 | +$0.05 | $3.86B | $3.68B |  |
 | | Details | |
| 1/31/24 | Q423 | $0.55 | $0.51 | +$0.04 | $3.73B | $3.6B | |
| | Details | |
| 10/26/23 | Q323 | $0.50 | $0.48 | +$0.02 | $3.53B | $3.48B | = | | | Details | |
| 7/27/23 | Q223 | $0.53 | $0.49 | +$0.04 | $3.6B | $3.5B | |
| | Details | |
| 4/26/23 | Q123 | $0.47 | $0.43 | +$0.04 | $3.39B | $3.16B | |
| | Details | |
| 2/1/23 | Q422 | $0.45 | $0.47 | -$0.02 | $3.24B | $3.24B | |
| | Details | |
| 10/26/22 | Q322 | $0.43 | $0.44 | -$0.01 | $3.17B | $3.15B |  |
| | Details | |
| 7/27/22 |  |
Q222 | $0.44 | $0.42 | +$0.02 | $3.24B | $3.21B | |
| | Details |
